DE SCR39

Designates May 2-9, 2021, as "Tardive Dyskinesia Awareness Week" in Delaware during National Mental Health Awareness Month.

Recognizes that Tardive Dyskinesia is a movement disorder affecting people treated for mental health conditions including schizophrenia, bipolar disorder, and severe depression.

Notes that antipsychotic medications cause Tardive Dyskinesia in one out of every four patients receiving long-term treatment, with over 500,000 Americans diagnosed.

Acknowledges that the condition is characterized by involuntary muscle movements, can develop long after treatment begins or ends, and is often permanent.

Encourages all Delawareans to become better informed about Tardive Dyskinesia and references recent FDA approval of two new treatments for symptoms.